Table 1: The alterations in electromyographic recordings in all groups.

Normal controlCisplatin + salineCisplatin + 80 μg/kg oxytocinCisplatin + 160 μg/kg oxytocin

CMAP latency (ms)2.44 ± 0.022.58 ± 0.022.53 ± 0.052.51 ± 0.03
CMAP amplitude (mV)10.23 ± 0.36.3 ± 0.267.9 ± 0.328.6 ± 0.21#

Results were presented as mean ± standard error of mean.
< 0.05 versus control group; # < 0.05 versus cisplatin + saline group.